Prof. Sebastian Lourido speaks with Salon reporter Elizabeth Hlavinka about the risks associated with parasite cleanses. “When you cause significant changes in the intestine, you are at times obliterating many of the beneficial organisms that are helping us digest food, but in some cases, producing vitamins that are actually occupying that niche and preventing bad organisms from taking over,” says Lourido.
Dr. Mallika Marshall joins CBS Boston to discuss E-BAR, a new mobile robot designed to physically support the elderly and prevent them from falling as they move around their homes. Marshall notes that E-BAR could also “lift someone from sitting to standing or vice versa, and catch someone safely by rapidly inflating side airbags if they begin to fall.”
Syntis Bio, a biopharmaceutical company co-founded by Prof. Giovanni Traverso and Prof. Robert Langer, is developing a daily obesity pill that mimics the effects of gastric bypass, reports Emily Mullin for Wired. “This material is something you would take as a capsule or liquid, but the next day it's gone because of the natural turnover of our mucosal surface in the GI tract,” says Traverso.
Deborah Blum, director of the Knight Science Journalism Program, writes for The New York Times about the history and future of food safety programs in the U.S. “The United States clearly still needs the safety systems that were so painstakingly built over the last 120 years, and to make them better and stronger,” writes Blum. “The labs and scientists and inspection teams that have been recently lost should not only be restored but expanded. And the mistakes of the 19th century should stay firmly in the history books.”
“AT MIT innovation ranges from awe-inspiring technology to down-to-earth creativity,” notes Chronicle during a visit to campus to peek behind the scenes at the innovations underway at the Institute. Classes taught by Prof. Erik Demaine are a “mix of rigorous math and creative collaboration,” host Anthony Everett explains, highlighting how Demaine’s work in computational origami has found its way into practical applications in such fields as medicine, architecture and space exploration. “I think origami provides a really powerful tool for making transformable shapes,” Demaine relates.
Chronicle visits MIT to learn more about how the Institute “nurtures groundbreaking efforts, reminding us that creativity and science thrive together, inspiring future advancements in engineering, medicine, and beyond.” Prof. Julien de Wit and Research Scientist Artem Burdanov discuss their planetary defense efforts aimed at identifying small asteroids that could pose a threat to Earth, and Prof. Canan Dağdeviren demonstrates her work developing ultrasound devices to detect the earliest stages of breast cancer. Host Anthony Everett notes that: “Big ideas have a way of breaking out of conventional boundaries, just part of what makes MIT one giant laboratory of groundbreaking ideas."
Rachel Feltman of Scientific American’s “Science Quickly” podcast visits MIT.nano to learn more about MIT’s “clean laboratory facility that is critical to nanoscale research, from microelectronics to medical nanotechnology.” Prof. Vladimir Bulović, director of MIT.nano, explains: “Maybe a fifth of all of M.I.T.’s research depends on this facility…from microelectronics to nanotechnology for medicine to different ways of rethinking what will [the] next quantum computation look like. Any of these are really important elements of what we need to discover, but we need all of them to be explored at the nanoscale to get that ultimate performance.”
Prof. Jeffrey Harris speaks with Newsweek reporter Jasmine Laws about how a recession could impact Medicare. "A recession could impact many critical decisions of federal lawmakers, private insurers, healthcare providers, and patients,” says Harris. “The U.S. Congress may decide to let stand the Medicare physician payment cut that became effective on January 1 of this year. Reduced physician payments under conventional Medicare may cause doctors, hospitals and other providers to shift their resources toward the care of younger, commercially insured patients."
Writing for The Boston Globe, Prof. Pierre Azoulay and Prof. Jeffrey Flier of Harvard Medical School make the case that any reforms at the NIH “should be grounded in evidence rather than tradition, avoiding the influence of special interests or political considerations.” They add that this approach “is an acknowledgement of NIH’s accomplishments and a charge to adapt it to the new realities of 21st-century science. The overarching goal must be to secure and enhance the decades-long role of the United States at the forefront of biomedical research, an outcome that the public both wants and deserves.”
MIT has multiple projects represented in this year’s STAT Madness, a bracket-style competition “highlighting important scientific advances emerging from labs at the nation’s universities, medical schools, and other U.S. research institutions and companies,” reports STAT staff.
Evan Ehrenberg PhD '16 co-founded Waterlily, a company that “uses artificial intelligence to predict a family’s future long-term care needs and costs” with the right care and financial planning, reports Mary Ann Azevedo for TechCrunch. “Ehrenberg — who had previously founded and sold Clara Health — helped with early research and was struck by the industry’s response,” writes Azevedo. “Curious, he tested the platform and was shocked by his long-term care predictions — so much so that he changed his diet, hired a personal trainer, and updated his financial plans.”
In an article for The New York Times, Prof. Pranav Rajpurkar of Harvard and Prof. Eric J. Topol of Scripps highlight a recent study by MIT researchers that examined “how radiologists diagnose potential diseases from chest X-rays.” They write that the study’s findings “broadly indicate that right now, simply giving physicians A.I. tools and expecting automatic improvements doesn’t work. Physicians aren’t completely comfortable with A.I. and still doubt its utility, even if it could demonstrably improve patient care.”
WCVB-TV's Chronicle spotlights Prof. Linda Griffith, “a forerunner in the field of biological engineering,” for her research investigating endometriosis and breaking the stigma around menstruation. Griffith founded the MIT Center for Gynepathology Research in 2009 and “one of their objectives is to help develop ways of staging endometriosis, similar to how cancer is characterized.” Griffith notes that by focusing on menstruation and making it a science, “I think we will really change the game for women.
Prof. Giovanni Traverso speaks with GBH’s “All Things Considered” host Arun Rath about his work developing new approaches to weight loss treatments that don’t involve surgery or pharmaceuticals. “Our team does a lot of work on ingestible systems, ingestible capsules that can do many things,” says Traverso. “You know, we recognize that we live now in a world where we have really incredible therapies that are very effective for the treatment of diabetes and obesity. But we also recognize that they’re not for everybody. There are people who have side effects, people who can’t take them, so these are certainly alternatives, or potentially synergistic interventions, that could work together either with those drugs or, as I was mentioning, for folks that have side effects from the drugs.”
Researchers at MIT have developed a new type of dynamic gastric balloon that inflates on demand and could be used to help patients feel more full before meals, reports Margherita Bassi for Gizmodo. The engineers have “designed a potential future alternative for patients who, for any number of reasons, cannot treat obesity through medications or invasive surgeries such as gastric bypass surgery or stapling,” writes Bassi.